Food and Drug Administration Healthcare Networking Pharmaceutical products 
Pharma Marketing Network
JULY 10, 2023
Pharmaceutical marketing is the process of communicating the benefits of a pharmaceutical product to potential patients and healthcare providers. It can be a complex and challenging process, as pharmaceutical companies must adhere to strict regulations while also developing creative and effective marketing campaigns.
Pharmaceutical Technology
MAY 16, 2023
It will benefit from Omega’s newly opened injectable manufacturing facility, which has received clearances from Health Canada and the US Food and Drug Administration, as well as from Juno’s commercial network and product development pipeline.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
AUGUST 23, 2022
The prevalence of fake drugs is a continually growing problem worldwide. Fake drugs can be categorised as substandard, falsified, counterfeit and diverted drugs, and the World Health Organization (WHO) broadly defines a counterfeit medicine as “one which is deliberately and fraudulently mislabelled with respect to identity and/or source.”
Pharma Marketing Network
AUGUST 9, 2023
The pharmaceutical industry operates in a highly regulated environment, where marketing and advertising practices are subject to rigorous scrutiny. Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products.
Pharma Marketing Network
AUGUST 9, 2023
The pharmaceutical industry operates in a highly regulated environment, where marketing and advertising practices are subject to rigorous scrutiny. Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products.
European Pharmaceutical Review
MARCH 12, 2024
In the pharmaceutical/life sciences industries, maintaining data integrity is crucial given its role in making critical decisions that shape outcomes from drug development to human health. Blockchain technology creates a decentralised and unalterable ledger that records all transactions across a network of computers.
European Pharmaceutical Review
APRIL 21, 2023
Seventy five percent of EU health systems’ emissions are released indirectly along the supply chain of pharmaceuticals, medical and other products. The environmental impact of the Dutch healthcare sector beyond climate change: an input-output analysis. 3 Credit: Steenmeijer M, et al. Lancet Planetary Health. 2022; 6: 949-57.
Expert insights. Personalized for you.
40 
Let's personalize your content